Skip to main content
Log in

Effectiveness of Repeat Angiographic Assessment in Patients Designated for Radioembolization Using Yttrium-90 Microspheres With Initial Extrahepatic Accumulation of Technitium-99m Macroaggregated Albumin: A Single Center’s Experience

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the efficacy of a workflow consisting of repeat assessment in patients planned for yttrium-90 (90Y) radioembolization in case of nontarget visceral technetium-99m (99mTc)-macroaggregated albumin (MAA) accumulation despite initial prophylactic coil embolization of nonhepatic arteries.

Materials and Methods

In 341 patients with primary and secondary liver cancer, pretreatment hepatic angiograms, as well as single-photon emission computed tomography coregistered with magnetic resonance imaging scans, were obtained. Extrahepatic tracer deposition was identified in 33 patients (9.7%) necessitating repeat assessment. Images were reviewed to correlate the site of MAA accumulation with causative gastrointestinal vessels, and repeat angiograms served as reference standard.

Results

At repeat angiography, the source of extrahepatic flow was identified and eliminated in 31 of 33 patients (93.9%). In 20 patients (60.6%), successful embolization of nontarget vessels was achieved, in 13 patients (39.4%), MAA was administered more distally. Afterward, extrahepatic MAA deposition was eliminated in 30 patients (90.9%).

Conclusion

The algorithm of repeat assessment in case of extrahepatic MAA accumulation has proven highly effective to eliminate extrahepatic shunting, thus decreasing the risk of postradioembolization complications due to inadvertent visceral microsphere deposition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jakobs TF, Hoffmann RT, Poepperl G, Schmitz A, Lutz J, Koch W, Tatsch K, Lubiensky A, Reiser MF, Helmberger T (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17:1320–1330

    Article  PubMed  Google Scholar 

  2. Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A III, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy, and survival. Radiology 247:507–515

    Article  PubMed  Google Scholar 

  3. Kennedy AS, Salem R (2010) Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies. Cancer J 16:163–175

    Article  PubMed  CAS  Google Scholar 

  4. Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, Het Schip AD, Nijsen JF (2009) Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 19:951–959

    Article  PubMed  CAS  Google Scholar 

  5. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213

    Article  PubMed  Google Scholar 

  6. Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, Sergie Z, Wong CY, Thurston KG (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639

    Article  PubMed  Google Scholar 

  7. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S41–S55

    Article  PubMed  Google Scholar 

  8. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M (2007) Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553–561

    Article  PubMed  Google Scholar 

  9. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A III, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Physiol 68:13–23

    Article  Google Scholar 

  10. Sjoquist KM, Goldstein D, Bester L (2010) A serious complication of selected internal radiation therapy: case report and literature review. Oncologist 15:830–835

    Article  PubMed  Google Scholar 

  11. Deleporte A, Flamen P, Hendlisz A (2010) State of the art: radiolabeled microspheres treatment for liver malignancies. Expert Opin Pharmacother 11:579–586

    Article  PubMed  Google Scholar 

  12. Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R (2007) Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30:571–592

    Article  PubMed  Google Scholar 

  13. Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547

    Article  PubMed  Google Scholar 

  14. Kim HC, Chung JW, Lee W, Jae HJ, Park JH (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 25(Suppl 1):S25–S39

    Article  PubMed  Google Scholar 

  15. Paprottka PM, Jakobs TF, Reiser MF, Hoffmann RT (2011) Practical vascular anatomy in the preparation of radioembolization. Cardiovasc Intervent Radiol. doi:10.1007/s00270-011-0169-z

  16. Denecke T, Ruhl R, Hildebrandt B, Stelter L, Grieser C, Stiepani H, Werk M, Podrabsky P, Plotkin M, Amthauer H, Ricke J, Lopez HE (2008) Planning transarterial radioembolization of colorectal liver metastases with yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol 18:892–902

    Article  PubMed  Google Scholar 

  17. Hamami ME, Poeppel TD, Muller S, Heusner T, Bockisch A, Hilgard P, Antoch G et al (2009) SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med 50:688–692

    Article  PubMed  CAS  Google Scholar 

  18. Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, Wilhelm K, Biersack HJ, Ezziddin S (2010) The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med 51:1206–1212

    Article  PubMed  Google Scholar 

  19. South CD, Meyer MM, Meis G, Kim EY, Thomas FB, Rikabi AA, Khabiri H, Bloomston M (2008) Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol 6:93

    Article  PubMed  Google Scholar 

  20. Yip D, Allen R, Ashton C, Jain S (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349

    Article  PubMed  Google Scholar 

  21. Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, Atassi B, Barrett K, Gowland P, Oman B, Lewandowski RJ, Gates VL, Thurston KG, Wong CY (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935

    Article  PubMed  Google Scholar 

  22. Abdelmaksoud MH, Hwang GL, Louie JD, Kothary N, Hofmann LV, Kuo WT, Hovsepian DM, Sze DY (2010) Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol 21:1385–1395

    Article  PubMed  Google Scholar 

  23. Pech M, Kraetsch A, Wieners G, Redlich U, Gaffke G, Ricke J, Dudeck O et al (2009) Embolization of the gastroduodenal artery before selective internal radiotherapy: a prospectively randomized trial comparing platinum-fibered microcoils with the Amplatzer Vascular Plug II. Cardiovasc Intervent Radiol 32:455–461

    Article  PubMed  Google Scholar 

  24. Inaba Y, Arai Y, Matsueda K, Takeuchi Y, Aramaki T (2001) Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 12:957–963

    Article  PubMed  CAS  Google Scholar 

  25. Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R (2008) Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol 19:691–697

    Article  PubMed  Google Scholar 

  26. Williams DM, Cho KJ, Ensminger WD, Ziessman HA, Gyves JW (1985) Hepatic falciform artery: anatomy, angiographic appearance, and clinical significance. Radiology 156:339–340

    PubMed  CAS  Google Scholar 

  27. Gibo M, Hasuo K, Inoue A, Miura N, Murata S (2001) Hepatic falciform artery: angiographic observations and significance. Abdom Imaging 26:515–519

    Article  PubMed  CAS  Google Scholar 

  28. Kim DE, Yoon HK, Ko GY, Kwon JS, Song HY, Sung KB (1999) Hepatic falciform artery: is prophylactic embolization needed before short-term hepatic arterial chemoinfusion? AJR Am J Roentgenol 172:1597–1599

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oliver Dudeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dudeck, O., Wilhelmsen, S., Ulrich, G. et al. Effectiveness of Repeat Angiographic Assessment in Patients Designated for Radioembolization Using Yttrium-90 Microspheres With Initial Extrahepatic Accumulation of Technitium-99m Macroaggregated Albumin: A Single Center’s Experience. Cardiovasc Intervent Radiol 35, 1083–1093 (2012). https://doi.org/10.1007/s00270-011-0252-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0252-5

Keywords

Navigation